A Dark Vector Cognition product

Item 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

6K characters. Original on sec.gov ·

Item 5. MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is quoted on the NASDAQ Global Select Market under the symbol IDXX. The following table shows the quarterly range of high and low sale prices per share (1) of our common stock as reported on the NASDAQ Global Select Market for the years 2015 and 2016.

For the Quarter EndedHighLow
March 31, 2015$84.26$72.38
June 30, 201582.2461.37
September 30, 201579.6261.58
December 31, 201577.2765.03
March 31, 201679.0363.48
June 30, 201692.8776.55
September 30, 2016115.0692.52
December 31, 2016121.77102.45

(1) 2015 Prices have been adjusted to reflect a two-for-one stock split on June 15, 2015.

Holders of Common Stock

As of February 6, 2017, there were 494 holders of record of our common stock. Because the majority of our common stock is held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.

Purchases of Equity Securities by the Issuer

During the three months ended December 31, 2016, we repurchased shares of common stock as described below:

1
PeriodTotal Number of Shares Purchased (a)Average Price Paid per Share (b)Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) (c)Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (d)
October 1, 2016 to October 31, 201667,500$110.6667,5005,619,425
November 1, 2016 to November 30, 20161,000,947108.651,000,9474,618,478
December 1, 2016 to December 31, 2016886,672117.24882,9703,735,508
Total1,955,119(2)$115.001,951,4173,735,508

(1) As of December 31, 2016, our Board of Directors had approved the repurchase of up to 65 million shares of our common stock in the open market or in negotiated transactions pursuant to the Company’s share repurchase program. The program was approved and announced on August 13, 1999, and the maximum number of shares that may be purchased under the program was subsequently increased on October 4, 1999, November 16, 1999, July 21, 2000, October 20, 2003, October 12, 2004, October 12, 2005, February 14, 2007, February 13, 2008, February 10, 2010, October 12, 2011, May 7, 2013 and again on July 16, 2014. Effective June 15, 2015, an additional 8 million shares of our common stock was authorized for repurchase, increasing the total shares of common stock authorized to be repurchased by the Company up from 57 million to 65 million shares. There is no specified expiration date for this repurchase program. There were no other repurchase programs outstanding during the three months ended December 31, 2016, and no repurchase programs expired during the period. Repurchases of 1,951,417 shares were made during the three months ended December 31, 2016, in transactions made pursuant to our repurchase program.

(2) During the three months ended December 31, 2016, we received 3,702 shares of our common stock that were surrendered by employees in payment for the minimum required withholding taxes due on the vesting of restricted stock units and settlement of deferred stock units. In the above table, these shares are included in columns (a) and (b), but excluded from columns (c) and (d). These shares do not reduce the number of shares that may yet be purchased under the repurchase program.

During the year ended December 31, 2016, we repurchased 3,070,644 shares of our common stock in transactions made pursuant to our repurchase program and received 59,860 shares of common stock that were surrendered by employees in payment for the minimum required withholding taxes due on the vesting of restricted stock units and settlement of deferred stock units. See Note 18 to the consolidated financial statements for the year ended December 31, 2016, included in this Annual Report on Form 10-K for further information.

Dividends

We have never declared or paid any cash dividends on our common stock. From time to time our Board of Directors may consider the declaration of a dividend. However, we have no intention to declare or pay a dividend at this time.

Stock Performance

This graph compares our total stockholder returns, the Total Return for the Standard & Poor’s (“S&P”) 500 Index, the Total Return for the S&P 500 Health Care Index and the Total Return for the NASDAQ Stock Market Index (U.S. Companies) prepared by the Center for Research in Security Prices (the “NASDAQ Index”). This graph assumes the investment of $100 on December 31, 2011, in IDEXX’s common stock, the S&P 500 Index, the S&P 500 Health Care Index and the NASDAQ Index and assumes dividends, if any, are reinvested. Measurement points are the last trading days of the years ended December 2011 to 2016.

Picture 3

12/31/201112/31/201212/30/201312/31/201412/31/201512/31/2016
IDEXX Laboratories, Inc.$100.00$120.58$138.23$192.66$189.50$304.76
NASDAQ Index100.00117.45164.57188.84201.98219.89
S&P 500 Health Care Index100.00117.89166.76209.02223.42217.41
S&P 500 Index100.00116.00153.57174.60177.01198.18

Previous: Item 3. LEGAL PROCEEDINGS · Next: Item 6. SELECTED FINANCIAL DATA